Learn From The Leaders: Biotech Stock Research On Seeking Alpha | Ed Ingham's 6-Tab Method [Seeking Alpha]
CRISPR Therapeutics AG - Common Shares (CRSP)
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/symbol/crsp/real-time
Company Research
Source: Seeking Alpha
For more insights from Edmund Ingham, join Haggerston BioHealth today! Follow Edmund Ingham at Haggerston BioHealth on Seeking Alpha! This video's transcript was generated by a third party. It is not curated or reviewed and is provided for convenience and information purposes only. The accuracy and completeness of the transcript are not guaranteed. Ed Ingham : Hi there. This is Ed Ingham, and I run the Investing Group, Haggerston BioHealth on Seeking Alpha. And in this video, I'm going to show you my approach to researching a new stock using some of the functionality that's provided by the Seeking Alpha Premium site. So, without further ado, let's get started. As you can see, I'm just on the Seeking Alpha homepage here. So, if I want to really do a due diligence deep dive on a stock, there are actually six tabs that I'd like to open. And I'm going to use the ticker CRSP, which is CRISPR Therapeutics, which is one of my favorite biotech stocks. So, I often look at this one. Bu
Show less
Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRSP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRSP alerts
High impacting CRISPR Therapeutics AG - Common Shares news events
Weekly update
A roundup of the hottest topics
CRSP
News
- CRISPR Therapeutics Stock: Is It a Bargain Buy Right Now? [Yahoo! Finance]Yahoo! Finance
- Is CRISPR Therapeutics Stock a Buy Now? [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics Balances CASGEVY Momentum With Early Pipeline Uncertainty [Yahoo! Finance]Yahoo! Finance
- Is Crispr Therapeutics (CRSP) The Best Gene-Editing Stock to Buy Now? [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics (CRSP) had its "overweight" rating reaffirmed by Piper Sandler. They now have a $110.00 price target on the stock, up from $105.00.MarketBeat
CRSP
Earnings
- 2/12/26 - Miss
CRSP
Sec Filings
- 3/24/26 - Form 4
- 3/24/26 - Form 4
- 3/24/26 - Form 4
- CRSP's page on the SEC website